EMESGEN
DEAD

Serial Number

97047211

Owner

EMESGEN PHARMACEUTICALS

Attorney

Derek Richmond

Filing Date

Sep 27, 2021

Add to watchlist:

No watchlists yet
View on USPTO

EMESGEN Trademark

Serial Number: 97047211

EMESGEN is a trademark filed by EMESGEN PHARMACEUTICALS on September 27, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

EMESGEN PHARMACEUTICALS

20 Duke Road
Piscataway, NJ 08854

Entity Type: 03

Trademark Details

Filing Date

September 27, 2021

Registration Date

Not Registered

Published for Opposition

August 9, 2022

Goods & Services

Pharmaceutical preparations for the treatment of infectious and parasitic diseases; Pharmaceutical preparations for the treatment of neoplasms; Pharmaceutical preparations for the treatment of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism; Pharmaceutical preparations for the treatment of endocrine, nutritional and metabolic diseases; Pharmaceutical preparations for the treatment of mental, behavioral and neuro developmental disorders; Pharmaceutical preparations for the treatment of diseases of the nervous system; Pharmaceutical preparations for the treatment of diseases of the eye and adnexa; Pharmaceutical preparations for the treatment of diseases of the ear and mastoid process; Pharmaceutical preparations for the treatment of diseases of the circulatory system; Pharmaceutical preparations for the treatment of diseases of the respiratory system; Pharmaceutical preparations for the treatment of diseases of the digestive system; Pharmaceutical preparations for the treatment of diseases of the skin and subcutaneous tissue; Pharmaceutical preparations for the treatment of diseases of the musculoskeletal system and connective tissue; Pharmaceutical preparations for the treatment of diseases of the genitourinary system, pregnancy, childbirth and the puerperium; Pharmaceutical preparations for the treatment of congenital malformations, deformations and chromosomal abnormalities

Advertising, marketing and promotion services; Business consulting services; Business consultation and management regarding marketing activities and launching of new products; Business to business direct marketing services; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 8, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 8, 2023 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 4, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 9, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 9, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 20, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 5, 2022 CNSA
ASSIGNED TO EXAMINER
Jun 27, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2021 NWOS
NEW APPLICATION ENTERED
Sep 30, 2021 NWAP